CTRI/2023/08/056165尚未招募3 期
Phase III Randomised Clinical Trial for stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy - OVHIPEC-2
Antoni Van Leeuwenhoek Netherlands Cancer Institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Candidate for primary CRS
- •2. Histological or cytological proven FIGO stage III primary epithelial ovarian, fallopian tube, or extra-ovarian cancer
排除标准
- •1.History of previous malignancies within 5 years prior to inclusion
- •2.FIGO stage IV disease
- •3.Complete primary cytoreduction is impossible
- •4.Prior treatment for the current malignancy
研究者
相似试验
进行中（未招募）
1 期
A study to see whether an extra rinse with chemotherapy during surgery will prolong the life of ovarian cancer patientsstage III epithelial ovarian cancerEUCTR2018-003346-17-NLKI-AV530
招募中
3 期
Phase III Randomized clinical trial for stage III epithelial ovarian cancer randomizing between primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy: OVHIPEC-210038594ovarian cancerNL-OMON55839Antoni van Leeuwenhoek Ziekenhuis400
进行中（未招募）
1 期
A study to see whether an extra rinse with chemotherapy during surgery will prolong the life of ovarian cancer patientsEUCTR2018-003346-17-SEKI-AV535
进行中（未招募）
1 期
A study to see whether an extra rinse with chemotherapy during surgery will prolong the life of ovarian cancer patientsEUCTR2018-003346-17-DKKI-AV535
进行中（未招募）
1 期
aEpithelial Ovarian Cancer stage IIIMedDRA version: 20.0Level: LLTClassification code 10006888Term: Ca ovarySystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10033163Term: Ovarian epithelial cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003346-17-ITTHE NETHERLANDS CANCER INSTITUTE538